Collaboration with Sareum Holdings

Southampton, UK – 13 December 2005 – Karus Therapeutics is pleased to announce it has entered into a collaborative agreement with AIM-listed Sareum Holdings plc, a specialist structure-based drug discovery and services business. Sareum will provide computational chemistry expertise to support Karus’s therapeutic discovery programmes based on inhibitors of histone deacetylase (HDAC). Financial terms of […]

Cancer and heart disease drug discovery company is latest spin-out from Southampton University

Southampton, UK – 21 July 2005 – A new spin-out company from the University of Southampton is aiming to make the treatment of cancer and heart disease more patient friendly. Chemist Dr A. Ganesan from the School of Chemistry, cancer scientist Dr Graham Packham and heart biologist Dr Paul Townsend from the School of Medicine […]